The preoperative lymphocyte to monocyte ratio predicts clinical outcomes in patients with stage II/III gastric cancer
详细信息 查看全文
- 作者：Xin Zhou (1)
Yiping Du (1)
Jun Xu (1)
Zebo Huang (1)
Tianzhu Qiu (1)
Xiaping Wang (3)
Jiaqi Qian (1)
Wei Zhu (1)
Ping Liu (1) (2) - 关键词：LMR ; Gastric cancer ; Prognosis
- 刊名：Tumor Biology
- 出版年：2014
- 出版时间：November 2014
- 年：2014
- 卷：35
- 期：11
- 页码：11659-11666
- 全文大小：716 KB
- 参考文献：1. Crew KD, Neugut AI. Epidemiology of gastric cancer. World J Gastroenterol WJG. 2006;12:354-2.
2. Siegel R, Naishadham D, Jemal A. Cancer statistics, 2012. CA Cancer J Clin. 2012;62:10-9. CrossRef
3. Lordick F, Kang YK, Chung HC, Salman P, Oh SC, Bodoky G, et al. Capecitabine and cisplatin with or without cetuximab for patients with previously untreated advanced gastric cancer (expand): a randomised, open-label phase 3 trial. Lancet Oncol. 2013;14:490-. CrossRef
4. Waddell T, Chau I, Cunningham D, Gonzalez D, Okines AF, Okines C, et al. Epirubicin, oxaliplatin, and capecitabine with or without panitumumab for patients with previously untreated advanced oesophagogastric cancer (REAL3): a randomised, open-label phase 3 trial. Lancet Oncol. 2013;14:481-. CrossRef
5. Coussens LM, Werb Z. Inflammation and cancer. Nature. 2002;420:860-. CrossRef
6. Mantovani A, Allavena P, Sica A, Balkwill F. Cancer-related inflammation. Nature. 2008;454:436-4. CrossRef
7. Grivennikov SI, Greten FR, Karin M. Immunity, inflammation, and cancer. Cell. 2010;140:883-9. CrossRef
8. Jiang X, Hiki N, Nunobe S, Kumagai K, Kubota T, Aikou S, et al. Prognostic importance of the inflammation-based Glasgow prognostic score in patients with gastric cancer. Br J Cancer. 2012;107:275-. CrossRef
9. Cho IR, Park JC, Park CH, Jo JH, Lee HJ, Kim S, Shim CN, Lee H, Shin SK, Lee SK, Lee YC: Pre-treatment neutrophil to lymphocyte ratio as a prognostic marker to predict chemotherapeutic response and survival outcomes in metastatic advanced gastric cancer. Gastric Cancer. 2014. doi: 10.1007/s10120-013-0330-2 .
10. Lee S, Oh SY, Kim SH, Lee JH, Kim MC, Kim KH, et al. Prognostic significance of neutrophil lymphocyte ratio and platelet lymphocyte ratio in advanced gastric cancer patients treated with FOLFOX chemotherapy. BMC Cancer. 2013;13:350. CrossRef
11. Shimada H, Takiguchi N, Kainuma O, Soda H, Ikeda A, Cho A, et al. High preoperative neutrophil-lymphocyte ratio predicts poor survival in patients with gastric cancer. Gastric Cancer. 2010;13:170-. CrossRef
12. Li ZM, Huang JJ, Xia Y, Sun J, Huang Y, Wang Y, et al. Blood lymphocyte-to-monocyte ratio identifies high-risk patients in diffuse large B-cell lymphoma treated with R-CHOP. PLoS One. 2012;7:e41658. CrossRef
13. Porrata LF, Ristow K, Colgan JP, Habermann TM, Witzig TE, Inwards DJ, et al. Peripheral blood lymphocyte/monocyte ratio at diagnosis and survival in classical Hodgkin’s lymphoma. Haematologica. 2012;97:262-. CrossRef
14. Stotz M, Pichler M, Absenger G, Szkandera J, Arminger F, Schaberl-Moser R, et al. The preoperative lymphocyte to monocyte ratio predicts clinical outcome in patients with stage III colon cancer. Br J Cancer. 2014;110:435-0. CrossRef
15. Li J, Jiang R, Liu WS, Liu Q, Xu M, Feng QS, et al. A large cohort study reveals the association of elevated peripheral blood lymphocyte-to-monocyte ratio with favorable prognosis in nasopharyngeal carcinoma. PLoS One. 2013;8:e83069. CrossRef
16. Balkwill F, Mantovani A. Inflammation and cancer: back to Virchow? Lancet. 2001;357:539-5. CrossRef
17. Penta R, De Falco M, Iaquinto G, De Luca A. / Helicobacter pylori and gastric epithelial cells: - 作者单位：Xin Zhou (1)
Yiping Du (1)
Jun Xu (1)
Zebo Huang (1)
Tianzhu Qiu (1)
Xiaping Wang (3)
Jiaqi Qian (1)
Wei Zhu (1)
Ping Liu (1) (2)
1. Department of Oncology, First Affiliated Hospital of Nanjing Medical University, 300 Guangzhou Road, Nanjing, 210029, China
3. Key Laboratory of Human Functional Genomics of Jiangsu Province, Clinical Diabetes Centre of Jiangsu Province, Nanjing Medical University, Nanjing, 210029, China
2. Cancer Center of Nanjing Medical University, Nanjing, 210029, China - ISSN：1423-0380
文摘
Recently, lymphocyte to monocyte ratio (LMR) has been reported to be associated with clinical outcomes in some types of cancer but has not been explored in gastric cancer. In this study, we analyzed the association between LMR and clinical outcomes in stage II/III gastric cancer patients. Preoperative LMR calculated from peripheral lymphocyte and monocyte with corresponding clinical features from 426 stage II/III gastric cancer patients was noted. Kaplan–Meier method and Cox regression model were applied for overall survival (OS) and recurrence-free survival (RFS). Related with smaller tumor size (p--.001), increased LMR could predict better OS [hazard ratio (HR), 0.688; 95?% confidence interval (CI), 0.521-.908, p--.008] and was borderline significantly associated with better RFS (HR, 0.775; 95?% CI, 0.592-.01, p--.06) in stage II/III gastric cancer patients through multivariable analysis. Subgroup analyses revealed that except stage III patients for RFS which yielded borderline significance (p--.052), lower LMR was associated with poor clinical outcomes for patients regardless of different stages or whether the patients received adjuvant chemotherapy. The elevated preoperative LMR level was a significant favorable factor in the prognosis of stage II/III gastric cancer patients, especially for those with stage II. However, further validation of our findings is warranted.